Login
$VRDN
$30.76 -$0.11 (0.36%) Live

Company Executives

Officer Age In this role Joined 2025 pay Source
Stephen Mahoney Also a director
President, Chief Executive Officer, and Director
55 Not stated Not stated $6,776,249
Seth Harmon
Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)
46 Not stated Not stated $2,642,779
Thomas Beetham
Chief Operating Officer
56 Since 2023
3 years
Not stated $3,761,182
Radhika Tripuraneni
Chief Medical Officer
46 Since 2025
1 year
2024 $4,080,466
Jennifer Tousignant
Chief Legal Officer
54 Since 2024
2 years
2024 $2,351,915

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
7
serving now
Independent
6 of 7
stated in the proxy
Average tenure
3.9 years
from year joined
CEO also chairs the board
No
Tomas Kiselak
Director Age On board Independent Other public boards 2025 pay Source
Tomas Kiselak
39 2020
6 years
Independent Apogee Therapeutics, Inc. $293,902
Stephen Mahoney
55 2023
3 years
Not independent None stated Paid as CEO
Jeff Ajer
63 2025
1 year
Independent Nektar Therapeutics $598,246
Chris Cain, Ph.D.
42 2025
1 year
Independent Cogent Biosciences, Inc., Jade Biosciences, Inc., Damora Therapeutics, Inc. Not stated
Sarah Gheuens, M.D., Ph.D.
47 2023
3 years
Independent None stated Not stated
Jennifer K. Moses
51 2021
5 years
Independent None stated $268,902
Arlene M. Morris
74 2018
8 years
Independent Palatin Technologies, Inc., Edgewise Therapeutics, Inc., Cogent Biosciences, Inc. $271,402

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

We could not read related-party transactions reliably

Rather than show a list that might be incomplete, we show nothing. They are in the proxy filed Apr 17, 2026, in its related person transactions section.

Read them in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support